Literature DB >> 19348843

Percutaneous aspiration thrombectomy for the treatment of acute lower extremity deep vein thrombosis: is thrombolysis needed?

S H Kwon1, J H Oh, T-S Seo, H J Ahn, H C Park.   

Abstract

AIM: To assess the technical feasibility and initial success of aspiration thrombectomy as a potential alternative to lytic therapy in initial endovascular management of acute lower extremity deep vein thrombosis (DVT).
MATERIALS AND METHODS: From July 2004 to October 2007, a retrospective analysis of 27 patients (male:female 5:22; mean age 59 years) with acute iliofemoral or femoropopliteal DVT of less than 2 weeks was performed. All patients underwent sonography of the lower extremities, and 13 patients underwent computed tomography (CT) venography. All patients received an inferior vena cava (IVC) filter and were initially treated with aspiration thrombectomy using the pullback technique with or without basket thrombus fragmentation. If persistent stenotic portions (>50% luminal narrowing) were noted, balloon angioplasty or stent placement was performed. Successful recanalization was defined as successful restoration of antegrade flow in the treated vein with elimination of any underlying obstructive lesion.
RESULTS: The mean procedure time was 65 min (range 40-100 min). Successful initial recanalization was achieved in 24 patients (88.9%) without complications. Urokinase was required for three patients (11.1%) due to a hard thrombus remaining in the iliac vein. Of the 27 patients, 23 had residual venous stenosis in the common iliac vein or external iliac vein. Therefore, balloon angioplasty (n=23) and stent placement (n=22) was performed. The remaining four patients were treated using only aspiration thrombectomy without angioplasty or stent placement.
CONCLUSION: Aspiration thrombectomy without catheter-directed thrombolysis is a safe and effective treatment for acute DVT of the lower extremities, and minimizes the risk of haemorrhagic complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348843     DOI: 10.1016/j.crad.2009.01.002

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

Review 1.  Catheter directed interventions for acute deep vein thrombosis.

Authors:  Maureen P Kohi; Ryan Kohlbrenner; Kanti P Kolli; Evan Lehrman; Andrew G Taylor; Nicholas Fidelman
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

2.  Endovascular treatment of iliofemoral deep vein thrombosis in pregnancy using US-guided percutaneous aspiration thrombectomy.

Authors:  Murat Gedikoglu; Levent Oguzkurt
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

3.  Safety and Efficacy of Aspiration Thrombectomy or Pharmacomechanical Thrombectomy after Catheter-Directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Vein Thrombosis.

Authors:  Joong Kwon Lee; Kyung Yun Kim; Seung Jae Byun
Journal:  Vasc Specialist Int       Date:  2020-09-30

4.  CD163 macrophage and erythrocyte contents in aspirated deep vein thrombus are associated with the time after onset: a pilot study.

Authors:  Eiji Furukoji; Toshihiro Gi; Atsushi Yamashita; Sayaka Moriguchi-Goto; Mio Kojima; Chihiro Sugita; Tatefumi Sakae; Yuichiro Sato; Toshinori Hirai; Yujiro Asada
Journal:  Thromb J       Date:  2016-11-22

5.  In vitro investigation of a new thrombus aspiration and autologous blood reinfusion system.

Authors:  Weixiao Li; Qiang Li; Shuiting Zhai; Tianxiao Li; Nick Cheshire; Zhidong Zhang; Kai Liang
Journal:  J Interv Med       Date:  2019-06-27

6.  The results of aspiration thrombecomy in the endovascular treatment for iliofemoral deep vein thrombosis.

Authors:  Jae Hoon Lee; Woo Hyung Kwun; Bo Yang Suh
Journal:  J Korean Surg Soc       Date:  2013-04-24

7.  Application of manual aspiration thrombectomy in the treatment of deep vein thrombosis in cancer patients: Descriptive retrospective cohort study.

Authors:  Eu Hyun Kim; Hae Giu Lee; Jung Suk Oh; Ho Jong Chun; Byung Gil Choi; Myung Ah Lee
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.